Impact of COVID-19 on Pregnancy.
Int J Med Sci. 2021; 18(3):763-767.IJ

Abstract

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is an emerging disease. There has been a rapid increase in cases and deaths since it was identified in Wuhan, China, in early December 2019, with over 4,000,000 cases of COVID-19 including at least 250,000 deaths worldwide as of May 2020. However, limited data about the clinical characteristics of pregnant women with COVID-19 have been reported. Given the maternal physiologic and immune function changes during pregnancy, pregnant women may be at a higher risk of being infected with SARS-CoV-2 and developing more complicated clinical events. Information on severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) may provide insights into the effects of COVID-19's during pregnancy. Even though SARS and MERS have been associated with miscarriage, intrauterine death, fetal growth restriction and high case fatality rates, the clinical course of COVID-19 pneumonia in pregnant women has been reported to be similar to that in non-pregnant women. In addition, pregnant women do not appear to be at a higher risk of catching COVID-19 or suffering from more severe disease than other adults of similar age. Moreover, there is currently no evidence that the virus can be transmitted to the fetus during pregnancy or during childbirth. Babies and young children are also known to only experience mild forms of COVID-19. The aims of this systematic review were to summarize the possible symptoms, treatments, and pregnancy outcomes of women infected with COVID-19 during pregnancy.

Links

PMC Free PDF

Authors+Show Affiliations

Wang CL

Department of Obstetrics and Gynecology, Kaohsiung Municipal Siaogang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Medical University, Kaohsiung, Taiwan. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. urolong@yahoo.com.tw.

Liu YY

Wu CH

Department of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung, Medical University, Kaohsiung, Taiwan.

Wang CY

Advanced mechanical engineering with management MSc, School of Engineering, University of Leicester, United Kingdom.

Wang CH

Department of Nursing, Fooyin University, Ta-Liao District, Kaohsiung, Taiwan.

Long CY

MeSH

AdultCOVID-19FemaleHumansInfant, NewbornInfectious Disease Transmission, VerticalMaternal ExposureMiddle East Respiratory Syndrome CoronavirusPregnancyPregnancy Complications, InfectiousPregnancy OutcomeSevere acute respiratory syndrome-related coronavirusSARS-CoV-2Severe Acute Respiratory SyndromeSeverity of Illness Index

Pub Type(s)

Journal Article

Systematic Review

Language

eng

PubMed ID

33437211

Citation

Wang, Chiu-Lin, et al. "Impact of COVID-19 On Pregnancy." International Journal of Medical Sciences, vol. 18, no. 3, 2021, pp. 763-767.

Wang CL, Liu YY, Wu CH, et al. Impact of COVID-19 on Pregnancy. Int J Med Sci. 2021;18(3):763-767.

Wang, C. L., Liu, Y. Y., Wu, C. H., Wang, C. Y., Wang, C. H., & Long, C. Y. (2021). Impact of COVID-19 on Pregnancy. International Journal of Medical Sciences, 18(3), 763-767. https://doi.org/10.7150/ijms.49923

Wang CL, et al. Impact of COVID-19 On Pregnancy. Int J Med Sci. 2021;18(3):763-767. PubMed PMID: 33437211.

* Article titles in AMA citation format should be in sentence-case

TY - JOUR T1 - Impact of COVID-19 on Pregnancy. AU - Wang,Chiu-Lin, AU - Liu,Yi-Yin, AU - Wu,Chin-Hu, AU - Wang,Chun-Yu, AU - Wang,Chun-Hung, AU - Long,Cheng-Yu, Y1 - 2021/01/01/ PY - 2020/06/25/received PY - 2020/11/13/accepted PY - 2021/1/13/entrez PY - 2021/1/14/pubmed PY - 2021/1/20/medline KW - Coronavirus disease 2019 (COVID-19) KW - Pregnancy KW - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) KW - Wuhan pneumonia SP - 763 EP - 767 JF - International journal of medical sciences JO - Int J Med Sci VL - 18 IS - 3 N2 - Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is an emerging disease. There has been a rapid increase in cases and deaths since it was identified in Wuhan, China, in early December 2019, with over 4,000,000 cases of COVID-19 including at least 250,000 deaths worldwide as of May 2020. However, limited data about the clinical characteristics of pregnant women with COVID-19 have been reported. Given the maternal physiologic and immune function changes during pregnancy, pregnant women may be at a higher risk of being infected with SARS-CoV-2 and developing more complicated clinical events. Information on severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) may provide insights into the effects of COVID-19's during pregnancy. Even though SARS and MERS have been associated with miscarriage, intrauterine death, fetal growth restriction and high case fatality rates, the clinical course of COVID-19 pneumonia in pregnant women has been reported to be similar to that in non-pregnant women. In addition, pregnant women do not appear to be at a higher risk of catching COVID-19 or suffering from more severe disease than other adults of similar age. Moreover, there is currently no evidence that the virus can be transmitted to the fetus during pregnancy or during childbirth. Babies and young children are also known to only experience mild forms of COVID-19. The aims of this systematic review were to summarize the possible symptoms, treatments, and pregnancy outcomes of women infected with COVID-19 during pregnancy. SN - 1449-1907 UR - https://www.unboundmedicine.com/medline/citation/33437211/Impact_of_COVID_19_on_Pregnancy_ DB - PRIME DP - Unbound Medicine ER -

Tags

Impact of COVID-19 on Pregnancy.Int J Med Sci. 2021; 18(3):763-767.IJ